The expression of FUCA-1 in BC patients with lymph node positive cancers, considering all molecular subtypes, was negative in 60% of patients against 40% being positive, thus suggesting that the lack of expression of FUCA-1 correlates with a more aggressive clinical behaviour of the tumor. The gene discussed is FUCA1; the disease is neoplasm.